Strategic Collaboration with CSHL

We are excited to announce a strategic collaboration with Dr. Christopher Vakoc at the Cold Spring Harbor Laboratory to develop new treatments for the childhood muscle cancer, rhabdomyosarcoma.  This joint effort between the Vakoc lab and the Keller laboratory (at cc-TDI) explores a new class of therapeutic targets using the most advanced genetic tools… those specially developed by the Vakoc laboratory to study leukemia.  This work is made possible by a coalition of community-based rhabdomyosarcoma advocates, who know only too well the need for new approaches to this disease.  We are grateful for their partnership.      

Share this post
Share on facebook
Share on google
Share on twitter
Share on linkedin